Demonstrating the value of cancer rehabilitation

At ReVital we feel it is our duty and privilege to do our part to move the science of cancer rehabilitation forward.

The goal of the ReVital Cancer Rehabilitation Research Program is to demonstrate the value of cancer rehabilitation in achieving the quadruple aim of better patient health and experience, and decreased total cost and clinician burden.

Under the guidance and direction of ReVital’s Senior Director of Research and Clinical Development, Mackenzi Pergolotti, Ph.D., OTR/L, our team is actively partnering with independent oncology practices and academic medical centers on several research initiatives aligned with value-based oncology care.

ReVital research key publications

The following select publications from the ReVital Research team demonstrate the need for and the impact of cancer rehabilitation services across the continuum.

Full-text articles

ASCO Abstracts published in the Journal of Clinical Oncology

Follow the ReVital research team

For research and professional collaborative requests email [email protected] or [email protected]

Take Your Next Step with ReVital